Knowledge%20Translation%20(and%20Exchange)%20for%20Vaccine-Preventable%20Diseases%20(VPDs) - PowerPoint PPT Presentation

About This Presentation
Title:

Knowledge%20Translation%20(and%20Exchange)%20for%20Vaccine-Preventable%20Diseases%20(VPDs)

Description:

Knowledge Translation (and Exchange) for Vaccine-Preventable Diseases (VPDs) CPHA Conference May 27th, 2014 Lisa Paddle, Nurse Advisor – PowerPoint PPT presentation

Number of Views:90
Avg rating:3.0/5.0
Slides: 18
Provided by: cph66
Category:

less

Transcript and Presenter's Notes

Title: Knowledge%20Translation%20(and%20Exchange)%20for%20Vaccine-Preventable%20Diseases%20(VPDs)


1
Knowledge Translation (and Exchange) for
Vaccine-Preventable Diseases (VPDs)
  • CPHA Conference
  • May 27th, 2014
  • Lisa Paddle, Nurse Advisor

2
Presentation Outline
  • What is Knowledge Translation and Exchange (KTE)
    and why is it important?
  • KTE in context of Vaccine-Preventable Disease
    Surveillance
  • The right audience
  • The right time
  • The right tools
  • Additional Learning Resources/KTE Mechanisms

3
What is knowledge translation (KT) / exchange
(KTE)?
  • a dynamic and iterative process that includes
    synthesis, dissemination, exchange and
    ethically-sound application of knowledge to
    improve the health of Canadians, provide more
    effective health services and products and
    strengthen the health care system (Source
    Canadian Institutes of Health Research)
  • This process takes place within a complex system
    of interactions between researchers and knowledge
    users that vary in intensity, complexity and
    level of engagement depending on the nature of
    the research and the findings as well as the
    needs of the particular knowledge user

4
Knowledge Translation Models
  • Based on 31 planned action theories
  • Designed to be used by broad range of audiences
  • Key is importance of appropriate relationships
  • Fluid, non-linear

5
Knowledge translation is about the application
and use of the best available science to benefit
health and well-being.
Knowledge output
Knowledge uptake/ impact
The right information to the right people in the
right way at the right time
6
VPD Surveillance How to translate science to
knowledge
7
Who were our key surveillance stakeholders?
  • Government
  • PHAC (other Centres Divisions)
  • National Microbiology Laboratory (NML)
  • Health Canada (First Nations, Vaccine Regulation)
  • Provincial / Territorial (P/T) VPD / immunization
    programs
  • International organizations
  • Centres for Disease Control Prevention (CDC)
  • Pan-American Health Organization (PAHO)
  • World Health Organization (WHO)
  • Professional organizations
  • Canadian Paediatric Society (CPS)
  • Immunize Canada
  • Society for Obstetricians Gynaecologists (SOGC)
  • Canadian Public Health Association (CPHA)
  • Etc.
  • F-P-T / Expert Committees
  • Canadian Immunization Committee (CIC)
  • National Advisory Committee on Immunization
    (NACI)
  • Committee to Advise on Tropical Medicine and
    Travel (CATMAT)

Immunization and Respiratory Infectious Diseases
  • Immunization providers
  • Local public health units
  • Primary health providers
  • Hospitals
  • Long-Term Care Homes
  • Occupational health services
  • Research community
  • Canadian Association of Immunization research and
    Evaluation (CAIRE)
  • PHAC-CIHR Influenza Research Network (PCIRN)
  • Vaccine evaluation centres
  • IMPACT
  • Individual researchers students
  • General public
  • Individuals / parents
  • Media
  • Public advocacy groups

8
What was our key mechanism?
9
  • Objectives of Vaccine-Preventable Disease
    Surveillance
  • To provide timely, quality national surveillance
    data to detect trends in disease incidence
  • To provide information to support program
    planning and evaluation, outbreak response and
    future policy and program decision-making
  • To increase knowledge and understanding of the
    epidemiology of vaccine preventable diseases
    through innovative enhanced surveillance systems
    and research

10
Goal of Knowledge Translation in the Context of
VPD Surveillance
  • To align national VPD surveillance products with
    the information needs of key partners
    stakeholders and effectively (and efficiently)
    inform immunization and vaccine-preventable
    disease program decisions.
  • VPDs include
  • Invasive meningococcal disease (IMD) Varicella
  • Invasive pneumococcal disease (IPD) Polio
  • Pertussis Diphtheria
  • Measles Tetanus
  • Mumps Haemophilus influenza disease
  • Rubella GBS/iGAS

11
KTE Strategy for Vaccine-Preventable Disease
Surveillance
KTE on Vaccine-Preventable Diseases
  • Notifiable Diseases On-line for aggregate case
    counts at the national level
  • Routine cycle for publication of surveillance
    reports up to 2023 (Canada Communicable Disease
    Reports)
  • Q1 (Polio/AFP measles rubella CRS)
  • Q2 years (IMD)
  • Q 5 years (Invasive Bacterial Diseases including
    Hi, IPD, iGBS, iGAS, International Circumpolar
    Surveillance, Pertussis)
  • Exploring options around weekly online measles
    reports
  • VPD surveillance on Agency Website
  • All products (e.g. Canadian Immunization Guide)
    will point here.
  • National Advisory Committee on Immunization
    (NACI) Statements
  • For product or strain-specific epidemiologic
    analysis
  • Peer Review journals for specific level of
    analysis
  • Disease Guidelines for epidemiologic summaries

12
Government of Canada Web Renewal Action Plan
(GCWRAP)
  • www.Canada.ca by the end of 2016
  • One website
  • User-centric
  • Modernized, leaner
  • Accessible (hand-held devices as well as
    assistive technologies)
  • Resources

This single site (Canada.ca) approach will
require that the Government of Canada
fundamentally transform its web presence to
better meet the needs of Canadians by being
user-centric.
13
Immunization and Vaccines Landing Page (before)
14
Immunization and Vaccines Landing Page (After)
http//www.phac-aspc.gc.ca/im/index-eng.php
15
New Vaccine-Preventable Diseases Landing Pages
  • General Public (plain language) AND Health
    Professional audiences
  • De-duplication
  • Audience-specific
  • Organized and easy to navigate
  • Hyperlinks to relevant content
  • Images/sounds, as appropriate
  • Surveillance section How is surveillance done
    on this VPD in Canada?
  • Health Professionals information and resources
    specific to Health Professionals

16
Select KTE Learning Resources
KTE on Vaccine-Preventable Diseases
  • PHAC Knowledge Translation Primer
    (http//publications.gc.ca/collections/collection_
    2013/aspc-phac/HP35-37-2012-eng.pdf)
  • National Collaborating Centre for Methods and
    Tools (http//www.nccmt.ca/)
  • CIHR Population and Public Health Institute
    (http//www.cihr-irsc.gc.ca/e/27155.html)
  • KT Clearinghouse www.ktclearinghouse.ca
  • Institute for Knowledge Mobilization
    (www.knowledgemobilization,net)
  • Health Evidence (www.health-evidence.org)

Some KTE mechanisms for Vaccine-Preventable
diseases Public Health Agency of Canada Website
Immunization and Vaccines Canadian Immunization
Guide Canada Communicable Disease Reports
(CCDR) CNPHI (Canadian Network for Public Health
Intelligence) (Public Health Alerts)
17
Acknowledgements
  • Heather Deehan, Chief Vaccine Preventable
    Diseases (PHAC)
  • Anita Li, Tiffany Smith, Amanda Shane, Lindsey
    Sherrard, Epidemiologists VPD section (PHAC)
  • Dr. Shalini Desai, Medical Specialist (PHAC)
  • Nadine Abboud, Project Management Support (PHAC)
  • Monique St-Laurent, A/Director Vaccine and
    Immunization Program Surveillance Division (PHAC)
  • Dr. John Spika, Director General, Centre for
    Immunization and Respiratory Infectious Diseases
    (CIRID) (PHAC)
  • Robert Lerch, Oliver Baclic, Althea House, CIG
    secretariat (PHAC)
  • Tara Harris, Public Health Ontario(formerly PHAC)
Write a Comment
User Comments (0)
About PowerShow.com